Ex Vivo Organoid Drug Sensitivity-Guided Treatment for Metastatic Pancreatic and Gastric Cancer (ODYSSEY) 公告 2024-12-17 17:16:03 Written By Kym Kilbourne Title: Ex Vivo Organoid Drug Sensitivity-Guided Treatment for Metastatic Pancreatic and Gastric Cancer (ODYSSEY) ClinicalTrials.gov ID: NCT05842187 Sponsor: Shan Jianzhen, MD Provider of Information: Shan Jianzhen, MD, The First Affiliated Hospital of Zhejiang University (Responsible Party) Last Update Posted: 2023-05-06 Study Overview Brief Summary The purpose of this study is to assess the consistency of ex vivo organoid drug sensitivity and the efficacy of in vivo drug therapy for tumors. Participants must provide a fresh tumor tissue sample (including ascites, pleural effusion, biopsy tissue, palliative surgery specimens, etc.) for the cultivation of tumor organoids. Official Title A Multicenter, Prospective, Exploratory Study to Evaluate the Effectiveness of Treatment Regimens for Metastatic Pancreatic and Gastric Cancer Guided by Ex Vivo Tumor Drug Sensitivity Test Organoids Conditions Pancreatic Cancer Gastric Cancer Interventions/Treatments Procedure: Tumor Tissue Biopsy Organoid Culture Other Study ID Numbers IIT20230001C-R1 Contact and Location Information Study Contact Name: Liu Zhen, MD Phone: +86-571-87235409 Email: liuzhen@cancer.ac.cn Study Link: https://clinicaltrials.gov/study/NCT05842187?term=organoid%20Guided&aggFilters=status:rec&rank=9 Kym Kilbourne
Ex Vivo Organoid Drug Sensitivity-Guided Treatment for Metastatic Pancreatic and Gastric Cancer (ODYSSEY) 公告 2024-12-17 17:16:03 Written By Kym Kilbourne Title: Ex Vivo Organoid Drug Sensitivity-Guided Treatment for Metastatic Pancreatic and Gastric Cancer (ODYSSEY) ClinicalTrials.gov ID: NCT05842187 Sponsor: Shan Jianzhen, MD Provider of Information: Shan Jianzhen, MD, The First Affiliated Hospital of Zhejiang University (Responsible Party) Last Update Posted: 2023-05-06 Study Overview Brief Summary The purpose of this study is to assess the consistency of ex vivo organoid drug sensitivity and the efficacy of in vivo drug therapy for tumors. Participants must provide a fresh tumor tissue sample (including ascites, pleural effusion, biopsy tissue, palliative surgery specimens, etc.) for the cultivation of tumor organoids. Official Title A Multicenter, Prospective, Exploratory Study to Evaluate the Effectiveness of Treatment Regimens for Metastatic Pancreatic and Gastric Cancer Guided by Ex Vivo Tumor Drug Sensitivity Test Organoids Conditions Pancreatic Cancer Gastric Cancer Interventions/Treatments Procedure: Tumor Tissue Biopsy Organoid Culture Other Study ID Numbers IIT20230001C-R1 Contact and Location Information Study Contact Name: Liu Zhen, MD Phone: +86-571-87235409 Email: liuzhen@cancer.ac.cn Study Link: https://clinicaltrials.gov/study/NCT05842187?term=organoid%20Guided&aggFilters=status:rec&rank=9 Kym Kilbourne
